Clinical Diagnostics Market

2020-2029 Report on Global Clinical Mass Spectrometry Market by Player, Region, Type, Application and Sales Channel | 9/7/2020

… perspectives in the Clinical Mass Spectrometry market. Leading players of Clinical Mass Spectrometry including: - Thermo Fisher Market split by Type, can be divided into: - LC-MS Market split by Application, can be divided into: - Clinical Diagnostics Market split by Sales Channel, can be divided into: - Direct Channel Market segment by Region/Country including: - North America (United States, Canada and Mexico) - Europe (Germany, UK, France, Italy, Russia and Spain etc.) - Asia …

Global Generic Hematology Analyzers and Reagents Market Size, Status and Forecast 2020-2026 | 9/2/2020

… the period 2015-2026. The key players covered in this study Abbott Laboratories Danaher Corporation Siemens Bio-Rad Laboratories Roche Sysmex Corporation Nihon Kohden Boule Diagnostics HORIBA BioSystems Diatron Drew Scientific EKF Diagnostics Mindray Ortho Clinical Diagnostics Market segment by Type, the product can be split into Generic Hematology Analyzers Generic Hematology Reagents Market segment by Application, split into Hospital Clinic Laboratory Other Market segment by Regions/Countries, this report covers …

SQI Diagnostics Inc. Announces Stock Option Grant | PR Newswire | 8/27/2020

… Shares). About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …

SQI Diagnostics Reports Third Quarter 2020 Results | PR Newswire | 8/27/2020

… protected] About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical-grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are “multiplexed”; which means many individual tests can now be simplified, consolidated and automated into a single test. This significantly increases sample throughput, reduces time …

SQI Diagnostics Appoints Rob Chioini as Chief Executive Officer, Grants Options and Amends Stock Option Plan | PR Newswire | 8/18/2020

… meeting. About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …

$PBIO Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device | 8/15/2020

… markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device | Wordpress.com | 8/14/2020

… markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device - QualityStocks | 8/14/2020

… markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Con | 8/14/2020

… markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device | 8/14/2020

… markets -Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) -The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business -The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device | 8/14/2020

… markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important …

Global Protein-based Multiplex Assays Market Size, Status and Forecast 2020-2026 | 8/13/2020

… BD Abcam Seegene Meso Scale Diagnostics Randox Laboratories Market segment by Type, the product can be split into Reagents & Consumables Instruments & Accessories Software & Services Market segment by Application, split into Companion Diagnostics Research & Development Clinical Diagnostics Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Protein-based Multiplex Assays status …

Global Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2020-2026 | 8/13/2020

… BD Abcam Seegene Meso Scale Diagnostics Randox Laboratories Market segment by Type, the product can be split into Reagents & Consumables Instruments & Accessories Software & Services Market segment by Application, split into Companion Diagnostics Research & Development Clinical Diagnostics Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Nucleic Acid-Based Multiplex Assays …

Covid-19 impact:Clinical Oncology NGS Market Is Expected At A CAGR Of 13.2% 2025 | Wordpress.com | 7/29/2020

… accelerate the growth of NGS technology in clinical diagnostics. Owing to the fact that next generation sequencing offers several advantages such as sensitivity, accuracy, and speed, this technology is anticipated to drive the oncology clinical diagnostics market . Furthermore, next generation sequencing aids in the assessment of multiple genes in a single assay, thereby eliminating the need to order several tests for determination of underlying mutation. North America held the dominant …

Industry Insights on Market Expansion into the US HbA1c Testing Market | Infiniti’s Free downloadable resource provides unparalleled insights | Business Wire | 7/16/2020

… View the full release here: https://www.businesswire.com/news/home/20200716005647/en/ Industry Insights on Market Expansion into the US HbA1c Testing Market (Graphic: Business Wire) In a span of six-weeks the client, a clinical diagnostics market player based out of APAC successfully actioned their market expansion plan in point-of-care testing for the HbA1c market in the United States and recorded substantial revenue growth using a highly targeted …

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024) | PR Newswire | 7/16/2020

… Market Forecast by Value 3.4 Global Multiplex Assays Market by Application 3.4.1 Global Multiplex Assays Research & Development Market by Value 3.4.2 Global Multiplex Assays Research & Development Market Forecast by Value 3.4.3 Global Multiplex Assays Clinical Diagnostics Market by Value 3.4.4 Global Multiplex Assays Clinical Diagnostics Market Forecast by Value 3.4.5 Global Multiplex Assays Companion Diagnostics Market by Value 3.4.6 Global Multiplex Assays Companion Diagnostics Market Forecast by Value 3.5 Global …

Global Automated and Rapid Microbiological Tests Industry | 7/14/2020

Global Automated and Rapid Microbiological Tests Industry By Reportlinker Read the full report: https://www.reportlinker.com/p04707098/?utm_source=PRN Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027.GC/CRT (Clinical), one …

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024) | 7/9/2020

… Software Forecast by Value (2020-2024)Global Multiplex Assays Market by Application (2019) Global Multiplex Assays Research & Development Market by Value (2015-2019)Global Multiplex Assays Research & Development Market Forecast by Value (2020-2024)Global Multiplex Assays Clinical Diagnostics Market by Value (2015-2019)Global Multiplex Assays Clinical Diagnostics Market Forecast by Value (2020-2024)Global Multiplex Assays Companion Diagnostics Market by Value (2015-2019)Global Multiplex Assays Companion Diagnostics Forecast by Value (2020-2024)Global Multiplex …

Global Clinical Diagnostics Market, By Type of Test, By Product, By Application, By Region, Competition, Forecast & Opportunities, 2025 | Globe Newswire | 4/16/2020

New York, April 16, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global Clinical Diagnostics Market, By Type of Test, By Product, By Application, By Region, Competition, Forecast & Opportunities, 2025” - https://www.reportlinker.com/p05885388/?utm_source=GNW Clinical diagnostics includes medical tests that are performed in a pathology or a diagnostic center or hospital or any other medical facility to diagnose or detect any disease or any other medical …

Global Clinical Diagnostics Market, By Type of Test, By Product, By Application, By Region, Competition, Forecast & Opportunities, 2025 | Globe Newswire | 4/16/2020

Global Clinical Diagnostics Market, By Type of Test, By Product, By Application, By Region, Competition, Forecast & Opportunities, 2025 Global Clinical Diagnostics Market, By Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software), By Application (Infectious Disease (COVID-19, Sepsis, HIV , Others), Cardiology, Cancer), By Region, Competition, Forecast & Opportunities, 2025 April 16, 2020 08:42 ET Source: ReportLinker New York, Reportlinker.com announces …

Bio-Rad Launches Serology Test to Detect Coronavirus Antibody - April 9, 2020 - Zacks.com | 4/9/2020

… company intends to use the FDA’s Emergency Use Authorization (“EUA”) to speed up the availability of the kit in the United States. With the launch, Bio-Rad aims to strengthen its position in the Clinical Diagnostics market globally. Significance of the Launch The human body’s antigen production is stimulated by the viral antigens to fight after being infected by the SARS-CoV-2. Per the company, the kit will enable …

Hospitals to Dominate Clinical Diagnostics Market Segment During Forecast Period | Wordpress.com | 3/24/2020

Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial …

pramod posted a blog post | 3/13/2020

Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market According to TechSci Research report, “ Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays, Hybridization, DNA Diagnostics, Others), Microbiology …

Clinical Diagnostics Market Scope, Size, Share, Growth, Trend and Forecast by 2025 | 3/13/2020

by mack nene TechSci Research Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market According to TechSci Research report, “ Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays …

$129+ Billion Biomarkers Industry by Type, Application, Disease and Region - Forecast to 2027 | PR Newswire | 3/11/2020

… by the growing obese population base and sedentary lifestyles Key Topics Covered Chapter 1 Methodology and Scope Chapter 2. Executive Summary Chapter 3. Biomarkers Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis 3.4.1.1. Increasing Prevalence of Chronic Diseases 3.4.1.2. Technological Advancements 3.4.1.3. Funding …

Siemens

$129+ Billion Biomarkers Industry by Type, Application, Disease and Region - Forecast to 2027 | PR Newswire | 3/11/2020

… CAGR, over the forecast period, spearheaded by India . Some key market players include Abbott, F. Hoffmann-La Roche Ltd., Qiagen, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson Services … Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis …

Clinical Diagnostics Market Study By Diagnostics, Applications & Top Key Players – Siemens Healthcare, Sonic Healthcare Ltd., Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare, Bio-Reference Laboratories | 5/31/2019

WordPress.com Clinical Diagnostics Market Study By Diagnostics, Applications & Top Key Players – Siemens Healthcare, Sonic Healthcare Ltd., Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare, Bio-Reference Laboratories The report enumerates the Clinical Diagnostics Market share held by the major players of the industry and delivers a full view of the competitive landscape. This market is categorized into different segments with the comprehensive analysis of each with respect to the geography …

Qiagen

$129+ Billion Biomarkers Industry by Type, Application, Disease and Region - Forecast to 2027 | PR Newswire | 3/11/2020

… fastest CAGR, over the forecast period, spearheaded by India . Some key market players include Abbott, F. Hoffmann-La Roche Ltd., Qiagen, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson … Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis …

Global Biomarkers Market Outlook, 2020-2027 - Featuring Profiles of Key Players Abbott, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio-Rad Labs, Johnson & Johnson Services, and More | Globe Newswire | 3/10/2020

… is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.Some key market players include Abbott, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson & Johnson Services, Agilent Technologies, and … Biomarkers Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook3.1.1. Clinical Diagnostics Market Outlook3.2. Penetration & Growth Prospect Mapping3.3. Regulatory Framework …

Abbott Laboratories

Global Clinical Diagnostics Market: Growth, Trends and Forecasts (2019-2024) - ResearchAndMarkets.com | Business & Finance | heraldchronicle.com | Business Wire | 11/28/2019

DUBLIN–(BUSINESS WIRE)–Nov 28, 2019– The “Clinical Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com ‘s offering. The clinical diagnostics market is driven by factors such as the … players. Some of the key players of the market include Abbott Laboratories, bioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics, among others. With the rising advances in the clinical …

ABT or BIO: Which Stock Has Better Potential Right Now? - Nasdaq.com | 7/15/2019

Abbott Laboratories ABT and Bio-Rad Laboratories BIO are two key players in the U.S. clinical diagnostics market. Let us run a comparative analysis of these two stocks, both carrying a Zacks Rank 3 (Hold). You can see the (Strong Buy) stocks here . Diagnostics is a significant part of IL-based Abbott’s business. Its product line comprises a broad range of diagnostic systems and tests manufactured, marketed and sold globally …

Andrew Morris

SQI Diagnostics to Announce Fourth Quarter and Fiscal 2019 Results | PR Newswire | 12/4/2019

… the fourth quarter and year ended September 30, 2019 , at 5:30 p.m. ET Wednesday, December 11 , 2019. President and CEO, Andrew Morris , along with Company management, will host a conference call on Thursday, December 12 … its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one …

SQI Diagnostics Reports Third Quarter 2019 Results | PR Newswire | 8/28/2019

… Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris , SQI’s President and CEO: “During the last quarter we achieved a significant milestone … its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one …